Shares of the biotech company soared early Tuesday, a day after the company said it sent vials to the National Institute of Allergy and Infectious ...
News
- Drugmaker readies possible coronavirus vaccine for testing
- Stocks sink, bonds soar on fears virus will stunt economy
The biotechnology company is one several drug developers racing to develop vaccine. The S&P 500 is on track for its first four-day losing streak since ...
- Lamont touts state-backed college-to-career program
The nine Stamford-based companies that have signed up so far to participate in the pilot encompass the biotechnology, information technology, ...
- Allakos Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
... College of Gastroenterology Annual Scientific Meeting (San Antonio, Texas; October 2019) by Dr. Evan Dellon, MD, MPH. ... Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory ...
- Intuit, Moderna rise; Mastercard, Shake Shack fall
The biotechnology company released a potential vaccine for the spreading coronavirus to the U.S. government for more tests. Intuit Inc., down $1.63 to ...